Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
147M
-
Number of holders
-
1135
-
Total 13F shares, excl. options
-
175M
-
Shares change
-
-2.6M
-
Total reported value, excl. options
-
$52.6B
-
Value change
-
-$839M
-
Put/Call ratio
-
1.22
-
Number of buys
-
425
-
Number of sells
-
-566
-
Price
-
$300.92
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q4 2018
1,313 filings reported holding BIIB - BIOGEN INC. - COM as of Q4 2018.
BIOGEN INC. - COM (BIIB) has 1,135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 175M shares
.
Largest 10 shareholders include BlackRock Inc. (16.6M shares), Vanguard Group Inc (15.2M shares), PRIMECAP MANAGEMENT CO/CA/ (14.7M shares), STATE STREET CORP (8.78M shares), Clearbridge Investments, LLC (8.73M shares), WELLINGTON MANAGEMENT GROUP LLP (5.4M shares), Capital World Investors (4.02M shares), FMR LLC (3.67M shares), AQR CAPITAL MANAGEMENT LLC (3.16M shares), and Invesco Ltd. (3.13M shares).
This table shows the top 1135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.